Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Busui Erxian Gao (補髓二仙膏) is a proprietary Traditional Chinese Medicine (TCM) product developed and marketed by Likang Biopharma. Formulated as a concentrated herbal paste or extract (Gao), it is designed to "supplement marrow" and "tonify the kidney," which are traditional concepts associated with supporting hematopoietic function and overall vitality. The product is primarily indicated for conditions involving bone marrow deficiency or suppression, such as aplastic anemia, leukopenia, and thrombocytopenia. It is also frequently used as a supportive therapy for patients undergoing chemotherapy or radiotherapy to help restore blood cell counts and mitigate myelosuppression. As an approved over-the-counter (OTC) product in China, it represents a key component of Likang Biopharma's consumer health and traditional medicine portfolio.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on busui erxian gao.